Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology
|
Buy Now
Navelbine (R) and Taxotere (R) - Histories of Sciences (Hardcover)
Loot Price: R2,568
Discovery Miles 25 680
You Save: R250
(9%)
|
|
Navelbine (R) and Taxotere (R) - Histories of Sciences (Hardcover)
Expected to ship within 12 - 17 working days
|
Among the many forms of cancer treatment, chemotherapy remains an
important part of the arsenal in which Navelbine and Taxotere play
a major role. These medicines result from molecules discovered by
French researchers of the Institut de Chimie des Substances
Naturelles (ICSN) of the CNRS, directed by Pierre Potier. By
recounting this history, the authors of this book attempt to
illustrate how the work of themselves and others, united in a
community, has helped obtain these results. After having explained
the strategy of the French policy makers to promote the French
chemistry of natural substances, the authors explore how the
academic efforts in this field have evolved, and the alignment
between science and its applications has become increasingly
present. The contributions of the CNRS to the industry, and vice
versa, offer an alternative image of public research relationships
and industrial research, where CNRS researchers are able to extend
the limits of freedom and creativity. It is to account for this
complexity that the authors here have chosen to write this history
together, which is in a sense exemplary. Due to an association
between history and chemistry, this book explains these discoveries
by placing them in their specific politic, economic and scientific
contexts.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.